Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials.

Source:http://linkedlifedata.com/resource/pubmed/id/21569417

Download in:

View as

General Info

PMID
21569417